Contract facts
FederalNo full NAICS 325414 intel page yet. Browse NAICS intelligence
THIRD TASK ORDER FOR THE PURCHASE OF OCTAPLASLG FOR PROGRAM EXECUTIVE OFFICE - OPERATIONAL MEDICINE is a federal award for Army Med Res Acq Activity held by Octapharma Usa Inc. Estimated value $1.8M ($1.8M obligated). Current period of performance ends May 24, 2026. Place of performance: TRENTON NJ.
THIRD TASK ORDER FOR THE PURCHASE OF OCTAPLASLG FOR PROGRAM EXECUTIVE OFFICE - OPERATIONAL MEDICINE
Recompete timing
PublicCurrent PoP ended May 24, 2026 (89 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordOctapharma Usa Inc — $9.2M obligated across 8 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT942525FE075?
HT942525FE075 (THIRD TASK ORDER for the purchase) is a Army Med Res Acq Activity award with a potential value of $1.8M, currently held by Octapharma Usa Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded HT942525FE075?
Army Med Res Acq Activity awarded HT942525FE075 to Octapharma Usa Inc (potential $1.8M).
Who is the incumbent on HT942525FE075?
Octapharma Usa Inc is the incumbent with $9.2M across 8 related awards in SCOUT’s public footprint. The current period of performance ends May 24, 2026.
When does Octapharma Usa Inc’s HT942525FE075 come up for recompete?
SCOUT tracks a period-of-performance end of May 24, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.